Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| CERE Historical Stock Prices |
| Preferred Stock Newsletter |
| CERE Options Chain |
| Stock Message Boards |
Cerevel Therapeutics Holdings (CERE) has the following price history information. Looking back at CERE historical stock prices for the last five trading days, on April 17, 2024, CERE opened at $41.47, traded as high as $41.80 and as low as $41.30, and closed at $41.60. Trading volume was a total of 838.00K shares. On April 18, 2024, CERE opened at $41.88, traded as high as $42.21 and as low as $41.70, and closed at $42.14. Trading volume was a total of 1.28M shares. On April 19, 2024, CERE opened at $42.01, traded as high as $42.23 and as low as $42.00, and closed at $42.21. Trading volume was a total of 813.30K shares. On April 22, 2024, CERE opened at $42.28, traded as high as $42.30 and as low as $41.86, and closed at $42.10. Trading volume was a total of 701.50K shares. On April 23, 2024, CERE opened at $42.10, traded as high as $42.14 and as low as $41.90, and closed at $41.99. Trading volume was a total of 1.39M shares.
CERE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cerevel Therapeutics Holdings shares, starting with a $10,000 purchase of CERE, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 07/31/2020 | |
| End date: | 04/23/2024 | |
| Start price/share: | $11.20 | |
| End price/share: | $41.99 | |
| Dividends collected/share: | $0.00 | |
| Total return: | 274.91% | |
| Average Annual Total Return: | 42.50% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $37,493.95 | |
| Years: | 3.73 | |
 | |||||
| CERE Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 04/17/2024 | $41.47 | $41.80 | $41.30 | $41.60 | 838.00K |
| 04/18/2024 | $41.88 | $42.21 | $41.70 | $42.14 | 1.28M |
| 04/19/2024 | $42.01 | $42.23 | $42.00 | $42.21 | 813.30K |
| 04/22/2024 | $42.28 | $42.30 | $41.86 | $42.10 | 701.50K |
| 04/23/2024 | $42.10 | $42.14 | $41.90 | $41.99 | 1.39M |
|
| About Cerevel Therapeutics Holdings |
| Cerevel Therapeutics Holdings is a clinical-stage biopharmaceutical company. Co.'s programs: Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype; Darigabat, which is a PAM that selectively targets the alpha-2/3/5 subunits of the GABAA receptor; Tavapadon, which is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of early- and late-stage Parkinson's disease; and CVL-871, which is a selective dopamine D1/D5 receptor partial agonist specifically designed to achieve a level of partial agonism. |
| CERE Historical Closing Prices | |
| Date | Close |
| 04/17/2024 | $41.60 |
| 04/18/2024 | $42.14 |
| 04/19/2024 | $42.21 |
| 04/22/2024 | $42.10 |
| 04/23/2024 | $41.99 |
| Healthcare Historical Prices |
| CERE is categorized under the Healthcare sector; below are some other companies in the same sector:
CERS Historical Stock Prices
|
Free CERE Email Alerts:
CERE Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.